UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000018596
Receipt No. R000021523
Official scientific title of the study Evaluation of enophthalmos due to ophthalmic solution for glaucoma
Date of disclosure of the study information 2015/08/07
Last modified on 2017/01/23 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Evaluation of enophthalmos due to ophthalmic solution for glaucoma
Title of the study (Brief title) Enophthalmos due to ophthalmic solution for glaucoma
Region
Japan

Condition
Condition Glaucoma
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Evaluation of enophthalmos due to ophthalmic solution for glaucoma
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Variation on a value of proptosis
Key secondary outcomes Variation on a volume of orbital fatty tissue

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Outpatients of Shiga University of Medical Science Hospital that start the treatment with bimatoprost ophthalmic solution for glaucoma
Key exclusion criteria Patients who have the history of the treatment with prostaglandin ophthalmic solution
Patients who can not undergo MRI examination
Target sample size 15

Research contact person
Name of lead principal investigator Tomoaki Higashiyama
Organization Shiga University of Medical Science
Division name Department of Ophthalmology
Address Seta, Tsukinowa-cho, Otsu, Shiga, Japan
TEL 0775482276
Email higashi@belle.shiga-med.ac.jp

Public contact
Name of contact person Tomoaki Higashiyama
Organization Shiga University of Medical Science
Division name Department of Ophthalmology
Address Seta, Tsukinowa-cho, Otsu, Shiga, Japan
TEL 0775482276
Homepage URL
Email higashi@belle.shiga-med.ac.jp

Sponsor
Institute Department of Ophthalmology, Shiga University of Medical Science
Institute
Department

Funding Source
Organization Scholarship donations
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 08 Month 07 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2015 Year 05 Month 21 Day
Anticipated trial start date
2015 Year 08 Month 07 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Prospective study
Cohort study
Consecutive cases

Management information
Registered date
2015 Year 08 Month 07 Day
Last modified on
2017 Year 01 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021523